Edward J. Brady

Statistics

Publications

Citations

672

H-Index

Active since

1984

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Edward J. Brady is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, molecular pharmacology, and receptor pharmacology.

Publications per year

1984–2018

Publications

Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cells

Richard Saperstein, Pasquale P. Vicario, H.V. Strout et al. · Biochemistry · 1989 · 108 citations

Life Sciences, Endocrinology, Pharmacology +17

Vanadate Treatment of Streptozotocin Diabetic Rats Restores Expression of the Insulin-Responsive Glucose Transporter in Skeletal Muscle

H.V. Strout, Pasquale P. Vicario, Chhabi Biswas et al. · Endocrinology · 1990 · 78 citations

Life Sciences, Endocrinology, Molecular Biology +15

Activation of Insulin Signal Transduction Pathway and Anti-diabetic Activity of Small Molecule Insulin Receptor Activators

Sajjad A. Qureshi, Victor Ding, Zhihua Li et al. · Journal of Biological Chemistry · 2000 · 67 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Discovery and investigation of a novel class of thiophene-derived antagonists of the human glucagon receptor

Joseph Duffy, Brian A. Kirk, Zenon Konteatis et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 57 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Approaches to peptidomimetics which serve as surrogates for the cis amide bond: novel disulfide-constrained bicyclic hexapeptide analogs of somatostatic.

Stephen F. Brady, William J. Paleveda, Byron H. Arison et al. · Tetrahedron · 1993 · 52 citations

Pharmacy, Chemistry, Medicinal Chemistry +12

1–5 of 15